لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Masanori Hashimoto, Hirohito Hirata, Masatsugu Tsukamoto, Yoshihara Tomohito, Masaaki Mawatari, Tadatsugu Morimoto

المصدر: Clinical Case Reports, Vol 11, Iss 9, Pp n/a-n/a (2023)

مصطلحات موضوعية: allograft bone, complications, deep vein thrombosis, graft migration, posterior lumbar intervertebral body fusion, vascular injury, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2050-0904

URL الوصول: https://doaj.org/article/808b0b7763b748468e89e37f8ed78094

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Shiramoto M; SOUSEIKAI Hakata Clinic, Fukuoka, Japan., Yoshihara T; SOUSEIKAI Hakata Clinic, Fukuoka, Japan., Schmider W; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany., Takahashi Y; Sanofi K.K., Tokyo, Japan., Nowotny I; Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany., Kajiwara M; Sanofi K.K., Tokyo, Japan., Muto H; Sanofi K.K., Tokyo, Japan.

المصدر: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Jun; Vol. 11 (6), pp. 754-760. Date of Electronic Publication: 2022 Feb 14.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE

مواضيع طبية MeSH: Biosimilar Pharmaceuticals*/adverse effects , Biosimilar Pharmaceuticals*/pharmacokinetics, Blood Glucose ; Cross-Over Studies ; Glucose ; Humans ; Hypoglycemic Agents ; Insulin Lispro ; Japan ; Male

المؤلفون: Sakamoto K; Souseikai Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan., Matsuki S; Souseikai Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan., Matsuguma K; Souseikai Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan., Yoshihara T; Souseikai Fukuoka Mirai Hospital Clinical Research Center, Fukuoka, Japan., Uchida N; Clinical Pharmacology, Pharmacology, Showa University School of Medicine, Tokyo, Japan., Azuma F; Research & Development, AstraZeneca KK, Osaka, Japan., Russell M; AstraZeneca, Protein Biomarkers, Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Alderley Park, UK., Hughes G; AstraZeneca, Protein Biomarkers, Personalised Healthcare and Biomarkers, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Alderley Park, UK., Haeberlein SB; Neuroscience, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Waltham, MA, USA., Alexander RC; Neuroscience, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Waltham, MA, USA., Eketjäll S; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Huddinge, Sweden., Kugler AR; Neuroscience, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Waltham, MA, USA.

المصدر: Journal of clinical pharmacology [J Clin Pharmacol] 2017 Nov; Vol. 57 (11), pp. 1460-1471. Date of Electronic Publication: 2017 Jun 15.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Amyloid Precursor Protein Secretases/*antagonists & inhibitors , Amyloid beta-Peptides/*metabolism , Aspartic Acid Endopeptidases/*antagonists & inhibitors , Cerebrospinal Fluid/*metabolism , Imidazoles/*therapeutic use , Plasma/*metabolism , Spiro Compounds/*therapeutic use, Adult ; Aged ; Alzheimer Disease/drug therapy ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Protein Precursor/metabolism ; Asian People ; Brain/metabolism ; Double-Blind Method ; Female ; Half-Life ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Peptide Fragments/metabolism ; Young Adult

المؤلفون: Nonaka M; Department of Clinical Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Morimoto S, Murayama T, Kurebayashi N, Li L, Wang YY, Arioka M, Yoshihara T, Takahashi-Yanaga F, Sasaguri T

المصدر: British journal of pharmacology [Br J Pharmacol] 2015 May; Vol. 172 (9), pp. 2369-82. Date of Electronic Publication: 2015 Mar 17.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Cardiomyopathy, Dilated/*drug therapy , Cardiotonic Agents/*pharmacology , Heart Failure/*drug therapy , Myocardial Contraction/*drug effects , Pyridazines/*pharmacology, Animals ; Calcium Channels, L-Type/drug effects ; Calcium Channels, L-Type/metabolism ; Calcium Signaling/drug effects ; Cardiomyopathy, Dilated/genetics ; Cardiomyopathy, Dilated/metabolism ; Cardiomyopathy, Dilated/physiopathology ; Cardiotonic Agents/toxicity ; Death, Sudden, Cardiac/etiology ; Death, Sudden, Cardiac/prevention & control ; Disease Models, Animal ; Disease Progression ; Female ; Heart Failure/genetics ; Heart Failure/metabolism ; Heart Failure/physiopathology ; Male ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Mutant Strains ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/metabolism ; Phosphodiesterase 3 Inhibitors/pharmacology ; Pyridazines/toxicity ; Risk Assessment ; Risk Factors ; Sarcoplasmic Reticulum/drug effects ; Sarcoplasmic Reticulum/metabolism ; Time Factors ; Troponin T/genetics ; Ventricular Function, Left/drug effects ; Ventricular Remodeling/drug effects

المؤلفون: Tsuboi H; University of Tsukuba, Ibaraki, Japan., Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, Hirota T, Miki H, Hagiwara S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Yoshihara T, Abe K, Sumida T

المصدر: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2014 Oct; Vol. 66 (10), pp. 2892-9.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Immunoglobulin G*, Autoimmune Diseases/*genetics , Salivary Glands/*metabolism , Sjogren's Syndrome/*genetics, Adult ; Aged ; Autoimmune Diseases/metabolism ; Autoimmune Diseases/pathology ; Female ; Gene Expression ; Humans ; Middle Aged ; Oligonucleotide Array Sequence Analysis ; Salivary Glands/pathology ; Sjogren's Syndrome/metabolism ; Sjogren's Syndrome/pathology ; Young Adult